Associated technologies
IgniteRF is a platform that brings together radiofrequency technologies for soft-tissue procedures.[1] Within the platform, QuantumRF 10 is described for smaller areas and QuantumRF 25 for larger areas. The technical material provided by Dr. Antônio lists cannula lengths of 10 cm and 25 cm, respectively. This difference does not define a hierarchy of quality; it relates to distinct anatomical and technical contexts.
The choice to use a device, and the way it may be incorporated into a procedure, requires discussion of anatomy, tissue characteristics, the treatment objective, medical history, examinations, the operative setting, anesthesia, and the available alternatives. Individual indication and availability must also be verified according to Brazilian regulation and the review of Dr. Antônio Teixeira.[1]
Complementary resources
The platform may enter selected protocols involving soft tissue when the surgeon considers radiofrequency an appropriate component of the proposed plan. QuantumRF 10 may be discussed in the facial laxity with Quantum IGNITE page; QuantumRF 25 may be contextualized in body and high-definition liposuction pages when radiofrequency forms part of planning for larger areas. The cannula size and technical approach depend on the anatomy and the plane discussed in consultation.[1]
This does not mean that every patient is a candidate, that every procedure requires the technology, or that the same configuration applies to different bodies or objectives. The confirmed scope includes protocols for facial laxity with Quantum IGNITE, but the exact role of the technology must remain individualized and subject to medical review.
The assessment
Assessment begins with the patient’s concerns and expectations, followed by examination and review of relevant clinical information. Skin quality, tissue distribution, weight changes, general health, prior procedures, examinations, and the characteristics of the proposed operation can all influence whether an energy-based resource is appropriate.
The planning process also considers the professional team, anesthesia, the hospital environment, follow-up, and the possibility that a surgical or non-surgical alternative may be more suitable. A technology does not replace this process and does not define a predetermined result.
Technology and care
| Technical element | Confirmed description | What remains individualized |
|---|---|---|
| Platform | IgniteRF gathers radiofrequency technologies for soft-tissue procedures.[1] | Whether radiofrequency belongs in the proposed plan. |
| QuantumRF 10 | A 10 cm cannula described for smaller areas.[1] | Selection for facial anatomy, access, tissue plane, and technical plan. |
| QuantumRF 25 | A 25 cm cannula described for larger areas.[1] | Selection for body areas, access, tissue plane, and technical plan. |
| Indication | May be considered in selected protocols when clinically appropriate. | Patient selection, objective, regulation, and availability. |
| Decision | A resource within evaluation and planning. | The complete treatment plan and alternatives. |
Follow-up
Follow-up is part of the treatment plan and is used to observe healing, discuss symptoms, and assess the course according to the procedure performed. The timing and content of visits depend on the individual plan and the team’s instructions. No device can establish an identical recovery path for all patients, and no recovery timeline should be promised in advance.
As with any procedure, the discussion should include limitations, possible adverse events, and circumstances in which the proposed intervention is not appropriate. The relevance of each concern depends on the patient, technique, context, and care provided. The equipment itself does not eliminate surgical or clinical risks.[2]
Technical resources
IGNITE/QuantumRF does not replace consultation, physical examination, laboratory or imaging evaluation when indicated, risk assessment, anesthesia planning, a suitable hospital environment, or postoperative follow-up. It does not define in advance skin contraction, an individual result, individual safety, less pain, faster recovery, or a defined contour. It does not eliminate laxity in every patient, and it does not make an operation appropriate when the clinical indication is absent.
It also does not authorize the same use in every country or for every patient. Regulatory status, equipment availability, professional responsibility, and the specific treatment plan must be checked before publication and before clinical use.[1]
Frequently asked questions
What is the difference between QuantumRF 10 and QuantumRF 25?
QuantumRF 10 is described for smaller areas and QuantumRF 25 for larger areas. This distinction does not make either cannula better; selection depends on the treatment area, anatomy, objective, and plan discussed in consultation.
Does every patient with facial laxity need Quantum IGNITE?
No. The indication depends on individual anatomy, clinical assessment, objectives, alternatives, and the applicable regulatory and technical context.
Can the technology defines in advance skin tightening?
No. The available technical material does not define an individual degree of contraction, contour, safety, or a predictable outcome.
Does IGNITE/QuantumRF reduce pain or shorten recovery?
No such claim should be made. Pain, healing, and recovery vary according to the patient, procedure, technique, and follow-up plan.
Does the device replace a consultation or examinations?
No. Consultation, examination, indicated tests, risk assessment, and shared planning remain necessary parts of deciding whether and how a technology may be used.
References
[1]: InMode — IgniteRF [2]: ASPS — Patient Safety [3]: ASPS — Liposuction
> Medical review note: Institutional information provided by Dr. Antônio Teixeira. Medical review is required before publication.